
Journal of Medicinal Chemistry p. 2591 - 2600 (1992)
Update date:2022-08-04
Topics:
Lowe, John A.
Drozda, Suzan E.
Snider, R. Michael
Longo, Kelly P.
Zorn, Stevin H.
et al.
We describe the structure-activity relationship development of a series of quinuclidines which culminated in the first potent, selective, nonpeptide substance P (SP) antagonist, (2S,3S)-cis-2-(diphenylmethyl)-N-<(2-methoxyphenyl)methyl>-1-azabicyclo<2.2.2
View MoreChengdu Pukang Biotechnology Co., Ltd
website:http://www.pu-kang.com
Contact:86-028-63976226
Address:No. 868 Xiwang Road,Xinjin county,Chengdu city, China
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
website:http://www.truewingroup.com
Contact:86-311-66699812
Address:NO.600 ZHONGSHAN EAST ROAD SHIJIAZHUANG
GUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
FUJIAN SHANSHUI CHEMICAL CORP.LTD.
Contact:+86-151-59920036
Address:Jinqiao Gareden, jo@fj-xinyi.com
Doi:10.1021/ja00975a028
(1966)Doi:10.1016/S0040-4039(00)78885-X
(1992)Doi:10.1021/ol303546p
(2013)Doi:10.1039/c2ob27221k
(2013)Doi:10.1021/ml300321d
(2013)Doi:10.1039/c2ce25841b
(2012)